Table 3.
Comparison of Biochemical indicators before surgery
| Parameter | No occurred (n = 676) | Occurred (n = 101) | t | P |
|---|---|---|---|---|
| TC (mmol/L) | 4.91 ± 1.31 | 4.88 ± 1.22 | 0.213 | 0.832 |
| TG (mmol/L) | 1.78 ± 0.33 | 1.73 ± 0.28 | 1.669 | 0.097 |
| HDL-C (mmol/L) | 1.19 ± 0.28 | 1.22 ± 0.33 | 0.747 | 0.455 |
| LDL-C (mmol/L) | 3.11 ± 0.95 | 3.12 ± 0.92 | 0.072 | 0.943 |
| APOA (g/L) | 1.44 ± 0.42 | 1.42 ± 0.38 | 0.429 | 0.668 |
| APOB (g/L) | 0.98 ± 0.31 | 0.98 ± 0.29 | 0.021 | 0.983 |
| FBG (mmol/L) | 6.78 ± 2.89 | 6.56 ± 2.87 | 0.715 | 0.475 |
| CEA/(ng/mL) | 158.66 ± 45.73 | 163.25 ± 46.32 | 0.939 | 0.348 |
| CA50/(U/mL) | 218.35 ± 74.87 | 216.87 ± 75.23 | 0.186 | 0.852 |
| CYFRA21-1/(ng/mL) | 175.12 ± 57.32 | 178.69 ± 56.91 | 0.584 | 0.559 |
| Scc-Ag/(ng/mL) | 93.45 ± 33.12 | 102.34 ± 36.24 | 2.486 | 0.013 |
TC: Total cholesterol; TG: Triglyceride; HDL-C: High density lipoprotein cholesterol; LDL-C: Low density lipoprotein cholesterol; APOA: Apoliprotein A; APOB: Apoliprotein B; FBG: Fasting blood glucose; CEA: Carcino Embryonic Antigen; CA50: Carbohydrate Antigen 50; CYFRA21-1: Cytokeratin 19 Fragment Antigen 21-1; Scc-Ag: Squamous Cell Carcinoma Antigen.